GSA CAPITAL PARTNERS LLP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$913
-30.9%
22,384
-34.6%
0.09%
-45.1%
Q4 2022$1,321
-99.8%
34,219
+56.4%
0.16%
-10.9%
Q1 2020$733,000
+16.0%
21,875
+31.8%
0.18%
+116.5%
Q3 2019$632,000
-59.7%
16,592
-54.0%
0.08%
-51.7%
Q2 2019$1,568,000
+393.1%
36,043
+387.1%
0.18%
+375.7%
Q4 2018$318,000
-68.5%
7,400
-75.3%
0.04%
-33.9%
Q2 2016$1,009,000
+88.6%
29,900
+196.0%
0.06%
+64.7%
Q1 2016$535,000
-59.2%
10,100
-45.6%
0.03%
-32.0%
Q2 2015$1,312,000
-45.8%
18,550
-31.9%
0.05%
-47.9%
Q1 2015$2,421,000
+185.8%
27,250
+185.3%
0.10%
+62.7%
Q4 2014$847,000
-34.6%
9,550
-28.6%
0.06%
-13.2%
Q3 2014$1,296,000
-42.5%
13,371
-58.5%
0.07%
-57.5%
Q1 2014$2,253,000
+147.9%
32,197
+103.7%
0.16%
+122.2%
Q4 2013$909,000
+188.6%
15,805
+141.2%
0.07%
+188.0%
Q3 2013$315,000
-41.4%
6,554
-64.6%
0.02%
-60.9%
Q2 2013$538,00018,5370.06%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,799,916$121,768,0008.62%
Tamarack Advisers, LP 625,000$27,044,0008.22%
NEXTHERA CAPITAL LP 149,086$6,484,0005.40%
Spyglass Capital Management LLC 379,609$16,509,0005.22%
Gagnon Advisors, LLC 107,412$4,671,0002.67%
GAGNON SECURITIES LLC 278,613$12,117,0002.61%
Asymmetry Capital Management, L.P. 84,735$3,685,0002.00%
Rock Springs Capital Management LP 1,250,000$54,363,0001.97%
Lisanti Capital Growth, LLC 118,620$5,159,0001.68%
Elk Creek Partners, LLC 500,069$21,748,0001.62%
View complete list of PACIRA PHARMACEUTICALS INC shareholders